ProCE Banner Activity

Using Novel Immune Modulatory Treatment Options in Head and Neck Cancer: Summary of Key Points for Practice

PDF
In this downloadable resource, Maura L. Gillison, MD, PhD highlights key points of immunotherapy in head and neck cancer, including current approved agents, management of immune-related adverse events, and a comprehensive list of current clinical trials.

Released: February 12, 2018

Expiration: February 11, 2019

No longer available for credit.

Share

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by an educational grant from

Bristol Myers Squibb